RESTORE-IMI 1: a multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections - Motsch, Johann; Murta de Oliveira, Cláudia; Stus, Viktor; Köksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W; Kaye, Keith S; File, Thomas M, Jr; Brown, Michelle L; Khan, Ireen; Du, Jiejun; Joeng, Hee-Koung; et al. (Clinical infectious diseases, 2020)
Published online August 10, 2019